# A Clinical Study Trial of Phenlarmide in China

> **NCT04164121** · PHASE1 · COMPLETED · sponsor: **Yiling Pharmaceutical Inc.** · enrollment: 36 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Phenlarmide Tablets
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04164121
- **Lead sponsor:** Yiling Pharmaceutical Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-17
- **Primary completion:** 2020-12-02
- **Final completion:** 2020-12-02
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2021-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04164121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04164121, "A Clinical Study Trial of Phenlarmide in China". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04164121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*